Author:
Ross Jeffrey S.,Linette Gerald P.,Stec James,Clark Edward,Ayers Mark,Symmans Fraser,Hortobagyi Gabriel N.,Pusztai Lajos
Reference107 articles.
1. Lacey JV Jr, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen. 2002;39:82–88.
2. Hilsenbeck SG, Clark GM, McGuire WL. Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat. 1992;22:197–206.
3. Nicholoson S, Richard J, Sainsbury C, et al. Epidermal growth factor receptor (EGFR): results of a six-year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer. 1991;63:146–150.
4. Castellani R, Visscher EW, Wykes S, et al. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. Cancer. 1994;73:344–349.
5. Tsutsui S, Kataoka A, Ohno S, et al. Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res. 2002;8:3454–3460.